Ignite Creation Date:
2024-05-06 @ 7:39 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06080828
Status:
COMPLETED
Last Update Posted:
2024-03-25
First Post:
2023-10-08
Brief Title:
Transdermal Neuromodulation for Management of Chronic Pelvic Pain in Women
Sponsor:
Kafrelsheikh University
Organization:
Kafrelsheikh University
Study Overview
Official Title:
Transdermal Neuromodulation for Management of Chronic Pelvic Pain in Women A Randomized Placebo-controlled Trial
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background Chronic pelvic pain CPP significantly impacts the quality of life in women This study investigated the effects of transdermal neuromodulation in females with CPP
Trial Design Parallel randomized single-blind controlled trial The aim of the study will be to examine the effect of posterior tibial nerve stimulation on women with idiopathic chronic pelvic pain syndrome
Methods Thirty females with chronic pelvic pain will be randomly allocated 11 to receive either transdermal neuromodulation of the posterior tibial nerve intervention group or advice to control posture control group for 4 weeks at the Outpatient Physical Therapy Clinic at Kafrelsheikh University in Egypt The primary outcome was pain intensity measured by visual analog scale VAS Secondary outcomes were serum cortisol level and quality of life QOL score Assessments will be done at baseline and after 4 weeks
Trial Design Parallel randomized single-blind controlled trial The aim of the study will be to examine the effect of posterior tibial nerve stimulation on women with idiopathic chronic pelvic pain syndrome
Methods Thirty females with chronic pelvic pain will be randomly allocated 11 to receive either transdermal neuromodulation of the posterior tibial nerve intervention group or advice to control posture control group for 4 weeks at the Outpatient Physical Therapy Clinic at Kafrelsheikh University in Egypt The primary outcome was pain intensity measured by visual analog scale VAS Secondary outcomes were serum cortisol level and quality of life QOL score Assessments will be done at baseline and after 4 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None